Stock Events

Stock Events

BBS-Bioactive Bone Substitutes 

0
0
+SEK0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation is a leading medical technology company that offers a range of orthopedic products, including bone substitutes, competing directly in BBS's market.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, including bone healing products which are in direct competition with BBS's offerings.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc provides advanced medical technologies, including bone graft solutions, which compete with BBS's bioactive bone substitute products.
Alphatec
ATEC
Mkt Cap1.55B
Alphatec Holdings, Inc. designs and develops spinal fusion technology, including biologics, which competes with BBS's bone healing products.
Orthofix Medical
OFIX
Mkt Cap370.26M
Orthofix Medical Inc. offers regenerative and orthopedic solutions, directly competing with BBS in the bone regeneration market.
K2 Capital Acquisition
KTWO
Mkt Cap201.81M
K2M Group Holdings, Inc. focuses on designing, developing, and commercializing innovative spine and minimally invasive solutions that compete with BBS.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a range of hospital and renal products, including biologics that are used in bone healing and regeneration, competing with BBS's products.

About

BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology firm, dedicated to innovating, manufacturing, and commercializing bioactive medical devices and implants for orthopedic surgical applications. The company's key offering, ARTEBONE, is an orthobiological product composed of tricalcium phosphate and a comprehensive spectrum of natural bone proteins. This solution is predominantly used for addressing bone deficiencies and aiding healing processes, especially in extremities such as the foot and ankle. BBS-Bioactive Bone Substitutes Plc commenced operations in 1991 and has its corporate headquarters situated in Oulu, Finland.
Show More
CEO
Juliusz Rakowskias
Employees
24
Country
Finland
ISIN
SE0017886005

Listings

ST
SE
BONES-BTA.ST
HE
FI
BONEH.HE

0 Comments

Share your thoughts

FAQs

What is BBS-Bioactive Bone Substitutes stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange BBS-Bioactive Bone Substitutes stocks are traded under the ticker BONES-BTA.ST.
How many employees does BBS-Bioactive Bone Substitutes have?▼
As of November 2, 2026, the company has 24 employees.
In which sector is BBS-Bioactive Bone Substitutes located?▼
BBS-Bioactive Bone Substitutes operates in the Health & Wellness sector.
When did BBS-Bioactive Bone Substitutes complete a stock split?▼
BBS-Bioactive Bone Substitutes has not had any recent stock splits.
Where is BBS-Bioactive Bone Substitutes headquartered?▼
BBS-Bioactive Bone Substitutes is headquartered in Oulu, Finland.